Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection
dc.contributor.author | Mendoza Lopez, Rossana Veronica | |
dc.contributor.author | Levi, Jose Eduardo | |
dc.contributor.author | Eluf-Neto, Jose | |
dc.contributor.author | Koifman, Rosalina Jorge | |
dc.contributor.author | Koifman, Sergio | |
dc.contributor.author | Curado, Maria Paula | |
dc.contributor.author | Michaluart-Junior, Pedro | |
dc.contributor.author | Alves Figueiredo, David Livingstone | |
dc.contributor.author | Saggioro, Fabiano Pinto | |
dc.contributor.author | Carvalho, Marcos Brasilino de | |
dc.contributor.author | Kowalski, Luiz Paulo | |
dc.contributor.author | Abrahão, Marcio [UNIFESP] | |
dc.contributor.author | Gois-Filho, Francisco de | |
dc.contributor.author | Tajara, Eloiza Helena | |
dc.contributor.author | Waterboer, Tim | |
dc.contributor.author | Boffetta, Paolo | |
dc.contributor.author | Brennan, Paul | |
dc.contributor.author | Wuensch-Filho, Victor | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Hosp Canc Barretos | |
dc.contributor.institution | Fundacao Oswaldo Cruz | |
dc.contributor.institution | Hosp Araujo Jorge | |
dc.contributor.institution | Int Prevent Res Inst | |
dc.contributor.institution | Hosp Heliopolis | |
dc.contributor.institution | Hosp Canc AC Camargo | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Inst Canc Arnaldo Viera Carvalho | |
dc.contributor.institution | Fac Med Sao Jose Rio Preto | |
dc.contributor.institution | German Canc Res Ctr | |
dc.contributor.institution | Mt Sinai Sch Med | |
dc.contributor.institution | Int Agcy Res Canc | |
dc.date.accessioned | 2016-01-24T14:35:30Z | |
dc.date.available | 2016-01-24T14:35:30Z | |
dc.date.issued | 2014-04-01 | |
dc.description.abstract | The role of human papillomavirus (HPV) on head and neck squamous cell carcinoma (HNSCC) survival in regions with low HPV prevalence is not yet clear. We evaluated the HPV16 infection on survival of HNSCC Brazilian patient series.This cohort comprised 1,093 HNSCC cases recruited from 1998 to 2008 in four Brazilian cities and followed up until June 2009. HPV16 antibodies were analyzed by multiplex Luminex assay. in a subset of 398 fresh frozen or paraffin blocks of HNSCC specimens, we analyzed for HPV16 DNA by L1 generic primer polymerase chain reaction. HNSCC survival according to HPV16 antibodies was evaluated through Kaplan-Meier method and Cox regression.Prevalence of HPV16 E6 and E6/E7 antibodies was higher in oropharyngeal cancer than in other head and neck tumor sites. HPV16 DNA positive in tumor tissue was also higher in the oropharynx. Seropositivity for HPV16 E6 antibodies was correlated with improved HNSCC survival and oropharyngeal cancer. the presence of HPV16 E6/E7 antibodies was correlated with improved HNSCC survival and oropharyngeal cancer survival. the death risk of oropharyngeal squamous cell carcinoma patients HPV16 E6/E7 antibodies positive was 78 % lower than to those who test negative.Oropharyngeal squamous cell carcinoma is less aggressive in the HPV16 E6/E7 positive serology patients. HPV16 E6/E7 antibody is a clinically sensible surrogate prognostic marker of oropharyngeal squamous cell carcinoma. | en |
dc.description.affiliation | Univ São Paulo, Fac Saude Publ, BR-01246904 São Paulo, Brazil | |
dc.description.affiliation | Hosp Canc Barretos, Inst Ensino & Pesquisa, Barretos, Brazil | |
dc.description.affiliation | Univ São Paulo, Inst Med Trop, BR-01246904 São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Fac Med, BR-01246904 São Paulo, Brazil | |
dc.description.affiliation | Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio de Janeiro, Brazil | |
dc.description.affiliation | Hosp Araujo Jorge, Goiania, Brazil | |
dc.description.affiliation | Int Prevent Res Inst, Lyon, France | |
dc.description.affiliation | Univ São Paulo, Fac Med, Hosp Clin, BR-01246904 São Paulo, Brazil | |
dc.description.affiliation | Univ São Paulo, Fac Med Ribeirao Preto, Hosp Clin, BR-14049 Ribeirao Preto, Brazil | |
dc.description.affiliation | Hosp Heliopolis, São Paulo, Brazil | |
dc.description.affiliation | Hosp Canc AC Camargo, São Paulo, Brazil | |
dc.description.affiliation | Universidade Federal de São Paulo, Hosp São Paulo, São Paulo, Brazil | |
dc.description.affiliation | Inst Canc Arnaldo Viera Carvalho, São Paulo, Brazil | |
dc.description.affiliation | Fac Med Sao Jose Rio Preto, São Paulo, Brazil | |
dc.description.affiliation | German Canc Res Ctr, Heidelberg, Germany | |
dc.description.affiliation | Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA | |
dc.description.affiliation | Int Agcy Res Canc, F-69372 Lyon, France | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Hosp São Paulo, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | European Commission | |
dc.description.sponsorshipID | FAPESP: 10/50733-6 | |
dc.description.sponsorshipID | FAPESP: 09/52031-1 | |
dc.description.sponsorshipID | FAPESP: 04/12054-9 | |
dc.description.sponsorshipID | European Commission: IC18-CT97-0222 | |
dc.format.extent | 461-471 | |
dc.identifier | http://dx.doi.org/10.1007/s10552-014-0348-8 | |
dc.identifier.citation | Cancer Causes & Control. Dordrecht: Springer, v. 25, n. 4, p. 461-471, 2014. | |
dc.identifier.doi | 10.1007/s10552-014-0348-8 | |
dc.identifier.issn | 0957-5243 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/37595 | |
dc.identifier.wos | WOS:000332647500006 | |
dc.language.iso | eng | |
dc.publisher | Springer | |
dc.relation.ispartof | Cancer Causes & Control | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://www.springer.com/open+access/authors+rights?SGWID=0-176704-12-683201-0 | |
dc.subject | Human papillomavirus | en |
dc.subject | Serology | en |
dc.subject | Prognosis | en |
dc.subject | Head and neck cancer | en |
dc.subject | Prevalence | en |
dc.title | Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection | en |
dc.type | info:eu-repo/semantics/article |